FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s Rizatriptan Benzoate as an original generic (ANDA) approval for the treatment of acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)